The Renal Cell Carcinoma Drug Market Will Experience Robust 3.7 Percent Annual ... - MarketWatch (press release) PDF Print
MarketWatch (press release)
BURLINGTON, Mass., Dec 08, 2011 (BUSINESS WIRE) -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the renal cell carcinoma drug market will experience robust 3.7 percent

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.